Search PubMed⌕ Search

PubMed · 8153755

Mental first aid.

Abstract

This paper reports a survey of staff of Oslo Sporveier who had been involved in serious incidents such as accidents resulting in severe personal injuries and death, suicide, robbery and assault. The survey was carried out to evaluate the efficacy of Mental First Aid in a retrospective study. The introduction of Mental First Aid was based on the beneficial effects from early intervention reported from follow-up studies after previous disasters, so for ethical reasons there was no control group. When help was given within the first few days without the use of any external specialists, and with strong support from colleagues during the first days back at work, there was little absenteeism. The beneficial effects of early intervention are stressed as is the use of non-professionals in forming a social network around employees who have been involved in traumatic incidents. Safety ombudsmen who have been given brief instruction are brought to the site of the incident to apply the principles of Mental First Aid. These secondary preventive measures are very effective and could be implemented by other medium-sized transport companies whose staff are exposed to the risk of suicide attempts.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

O T Foss. 1994. Mental first aid.. https://doi.org/10.1016/0277-9536(94)90451-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

In a two-stage detection program, subjects with signs of obstructive airway disease were selected from a random sample of the general population. Subjects (n = 82) were randomly assigned to either fluticasone propionate 250 microg twice a day or placebo twice a day via pMDI in a 1-yr, double-blind trial if they met criteria for persistent airway obstruction, increased bronchial hyperresponsiveness, or a rapid decline in FEV(1). Main outcome measures were postbronchodilator FEV(1), quality-adjusted life years (QALYs), and direct medical cost. Secondary measures were prebronchodilator FEV(1), PC(20), health-related quality of life (CRQ), symptom-free weeks, episode-free weeks, exacerbations, and indirect cost. Subgroup analysis was based on reversibility of obstruction. Analysis revealed a significant gain in postbronchodilator FEV(1) (98 ml/yr; p = 0.01) in favor of fluticasone. Only subjects with reversible obstruction showed an improvement in PC(20) (1.4 doubling dose; p = 0.03). Early treatment resulted in 2.7 QALYs gained per 100 treated subjects (p = 0.17) and in a clinically relevant improvement in dyspnea (CRQ; p < 0.03). The incremental cost effectiveness ratios were US$13,016/QALY for early treatment and US$33,921/QALY for the combination of detection and treatment. The incremental cost for one additional subject with a clinically relevant difference in dyspnea was US$1,674. In conclusion, early intervention with fluticasone resulted in significant health gains at relatively low financial cost.

Absenteeism↗